Allogene Therapeutics, Inc. · NASDAQ:ALLO

David D. Chang, M.D., Ph.D.'s stake in Allogene Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 12, 2025

David D. Chang, M.D., Ph.D.'s stake in Allogene Therapeutics, Inc. fell to 4.90%, 11,234,918 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G/A).

Stake
4.90%
Shares
11,234,918
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
David D. Chang, M.D., Ph.D.4.90%11,234,918
Chang 2006 Family Trust0.50%1,201,108
JEC 2019 Trust0.40%856,044
RTC 2019 Trust0.40%856,044

Source

View original at SEC

Related